Literature DB >> 19395958

Pertussis in early infancy: disease burden and preventive strategies.

Peter McIntyre1, Nicholas Wood.   

Abstract

PURPOSE OF REVIEW: Severe pertussis disease in early infancy remains a significant problem, both in developed countries with long-standing pertussis immunization programs and in poor countries. We review current understanding of the disease burden and potential prevention strategies. RECENT
FINDINGS: Even with intensive care support, infants with pertussis pneumonia still die, so prevention is the key. The source of pertussis in infants under 3 months of age is often not clear, but in countries with high childhood immunization coverage, the sources are usually adults. Strategies to protect these infants may be indirect (timely primary immunization and boosters for older children and adults) and direct (mother during pregnancy or infant soon after birth). 'Cocooning' by immunizing all potential adult contacts is probably the most effective indirect strategy but needs funding and programmatic support for successful implementation. Maternal immunization is attractive but unproven and has significant practical hurdles. The evidence on immunization at birth is conflicting and impact, including interference with response to other infant vaccines, is unclear.
SUMMARY: Adult booster immunization, either universal or targeted (mothers during pregnancy or 'cocoon'), would probably be effective but is challenging to implement. If shown to be safe and effective, immunization at birth has significant practical advantages. Different strategies (alone or combined) may be needed in different settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395958     DOI: 10.1097/QCO.0b013e32832b3540

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  34 in total

Review 1.  What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors:  Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

2.  Embedding the delivery of antenatal vaccination within routine antenatal care: a key opportunity to improve uptake.

Authors:  Christopher R Wilcox; Charlotte Woodward; Rebecca Rowe; Christine E Jones
Journal:  Hum Vaccin Immunother       Date:  2019-07-24       Impact factor: 3.452

3.  Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations.

Authors:  Heather Webb; Jackie Street; Helen Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-02-07       Impact factor: 3.452

Review 4.  Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.

Authors:  Edward Goldstein; Virginia E Pitzer; Justin J O'Hagan; Marc Lipsitch
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

5.  Current practice and attitudes towards vaccination during pregnancy: a survey of GPs across England

Authors:  Christopher R Wilcox; Paul Little; Christine E Jones
Journal:  Br J Gen Pract       Date:  2020-01-30       Impact factor: 5.386

Review 6.  Immunization During Pregnancy: Impact on the Infant.

Authors:  Kirsten P Perrett; Terry M Nolan
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

7.  Core pertussis transmission groups in England and Wales: A tale of two eras.

Authors:  Ana I Bento; Maria A Riolo; Yoon H Choi; Aaron A King; Pejman Rohani
Journal:  Vaccine       Date:  2018-02-01       Impact factor: 3.641

8.  Protecting infants from pertussis.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

9.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

10.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.